Generic Drugs & Pharmacy News

Image description

Report: Pfizer could split new company after Allergan merger

Following Monday’s announcement that Pfizer would be merging with Ireland-based company Allergan, some analysts are predicting that Pfizer would split the combined company following the $160 billion deal, Reuters reported. According to the report, the split would likely divide the company’s established products (i.e., generics) unit and its innovative medicines unit, composed of drugs that are still patent-protected. (Reuters)

Image description

Report: Pfizer-Allergan merger talks accelerate

With the U.S. Treasury announcing plans to crack down on tax-inversion deals on Thursday, pharmaceutical giants Pfizer and Allergen have accelerated their merger talks, according to reports. The potential $150 billion deal could see Pfizer redomicile in Ireland. (Reuters)